05:37:47 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-04-29 Årsstämma 2025
2025-04-29 Kvartalsrapport 2025-Q1
2025-02-28 Bokslutskommuniké 2024
2024-10-31 Kvartalsrapport 2024-Q3
2024-07-31 Kvartalsrapport 2024-Q2
2024-04-30 Ordinarie utdelning NNH 0.00 SEK
2024-04-29 Årsstämma 2024
2024-04-29 Kvartalsrapport 2024-Q1
2024-02-28 Bokslutskommuniké 2023
2023-10-31 Kvartalsrapport 2023-Q3
2023-07-31 Kvartalsrapport 2023-Q2
2023-04-28 Ordinarie utdelning NNH 0.00 SEK
2023-04-27 Kvartalsrapport 2023-Q1
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-29 Kvartalsrapport 2022-Q2
2022-04-29 Ordinarie utdelning NNH 1.25 SEK
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-28 Årsstämma 2022
2022-02-28 Bokslutskommuniké 2021
2021-10-29 Kvartalsrapport 2021-Q3
2021-07-30 Kvartalsrapport 2021-Q2
2021-04-30 Ordinarie utdelning NNH 1.50 SEK
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-29 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-10-30 Kvartalsrapport 2020-Q3
2020-07-31 Kvartalsrapport 2020-Q2
2020-04-30 Ordinarie utdelning NNH 1.75 SEK
2020-04-29 Kvartalsrapport 2020-Q1
2020-04-29 Årsstämma 2020
2020-02-28 Bokslutskommuniké 2019
2019-10-31 Kvartalsrapport 2019-Q3
2019-07-31 Kvartalsrapport 2019-Q2
2019-04-29 Ordinarie utdelning NNH 1.50 SEK
2019-04-25 Kvartalsrapport 2019-Q1
2019-04-25 Årsstämma 2019
2019-03-01 Bokslutskommuniké 2018
2018-10-31 Kvartalsrapport 2018-Q3
2018-07-31 Kvartalsrapport 2018-Q2
2018-04-27 Ordinarie utdelning NNH 1.15 SEK
2018-04-26 Kvartalsrapport 2018-Q1
2018-04-26 Årsstämma 2018
2018-03-02 Bokslutskommuniké 2017
2017-10-31 Kvartalsrapport 2017-Q3
2017-07-31 Kvartalsrapport 2017-Q2
2017-04-28 Ordinarie utdelning NNH 0.40 SEK
2017-04-27 Kvartalsrapport 2017-Q1
2017-04-27 Årsstämma 2017
2017-03-06 Bokslutskommuniké 2016
2016-10-31 Kvartalsrapport 2016-Q3
2016-07-29 Kvartalsrapport 2016-Q2
2016-04-29 Ordinarie utdelning NNH 0.25 SEK
2016-04-28 Årsstämma 2016
2016-04-28 Kvartalsrapport 2016-Q1
2016-03-07 Bokslutskommuniké 2015
2015-10-30 Kvartalsrapport 2015-Q3
2015-07-31 Kvartalsrapport 2015-Q2
2015-04-30 Ordinarie utdelning NNH 0.00 SEK
2015-04-29 Kvartalsrapport 2015-Q1
2015-04-29 Årsstämma 2015
2015-03-06 Bokslutskommuniké 2014
2014-10-31 Kvartalsrapport 2014-Q3
2014-07-31 Kvartalsrapport 2014-Q2
2014-05-01 Ordinarie utdelning NNH 0.00 SEK
2014-04-30 Årsstämma 2014
2014-03-07 Bokslutskommuniké 2013
2013-10-31 Kvartalsrapport 2013-Q3
2013-07-31 Kvartalsrapport 2013-Q2
2013-04-30 Ordinarie utdelning NNH 0.00 SEK
2013-04-29 Årsstämma 2013
2013-04-29 Kvartalsrapport 2013-Q1
2013-03-08 Bokslutskommuniké 2012
2012-10-31 Kvartalsrapport 2012-Q3
2012-07-31 Kvartalsrapport 2012-Q2
2012-05-01 Ordinarie utdelning NNH 0.00 SEK
2012-04-30 Årsstämma 2012
2012-04-30 Kvartalsrapport 2012-Q1
2012-03-09 Bokslutskommuniké 2011
2011-10-31 Kvartalsrapport 2011-Q3
2011-07-29 Kvartalsrapport 2011-Q2
2011-04-29 Kvartalsrapport 2011-Q1
2011-04-29 Årsstämma 2011
2011-03-11 Bokslutskommuniké 2010
2010-10-29 Kvartalsrapport 2010-Q3
2010-07-30 Kvartalsrapport 2010-Q2
2010-05-03 Ordinarie utdelning NNH 0.00 SEK
2010-04-30 Kvartalsrapport 2010-Q1
2010-02-26 Bokslutskommuniké 2009
2009-10-30 Kvartalsrapport 2009-Q3
2009-07-31 Kvartalsrapport 2009-Q2
2009-04-30 Kvartalsrapport 2009-Q1
2009-04-16 Årsstämma 1
2009-04-14 Ordinarie utdelning NNH 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHandel & varor
IndustriDetaljhandel
New Nordic Healthbrands är specialiserat mot att utveckla och marknadsföra kosttillskott och naturläkemedel. Största delen av sortimentet utgörs av hälsofrämjande örter. Produkterna säljs via bolagets återförsäljare och tillskotten används exempelvis inom hud- och hårvård, för förbättring av immunsystemet och synförmågan, samt som generella vitamintillskott. Huvudkontoret ligger i Malmö.
2017-07-31 08:59:56

SIX MONTHS 2017

  • Net sales amounted to MSEK 169.8 (150.5), an increase of 12.8 percent. In local currencies, the increase was 9.5 percent.
  •  Gross proft increased to MSEK 114.2 (98.0).
  • EBITDA increased to MSEK 9.4 (5.3).
  • Operating profit increased to MSEK 9.0 (4.7).
  • Profit after tax for the period increased to MSEK 6.7 (3.8).
  • Earnings per share increased to SEK 1.08 (0.62).

Q2 2017

  • Net sales amounted to MSEK 88.9 (76.0), an increase of 17.0 percent. In local currencies, the increase was 12.8 percent.
  • Gross profit increased to MSEK 59.7 (50.5).
  • EBITDA increased to MSEK 5.3 (2.1).
  • Operating profit increased to MSEK 5.1 (1.8).
  • Profit after tax for the period increased to MSEK 3.8 (1.5).
  • Earnings per share increased to SEK 0.61 (0.24).

COMMENTS BY KARL KRISTIAN BERGMAN JENSEN, CEO

We continued our growth in sales and earnings and reached record levels. We had a fine second quarter 2017 making the first half year a good half year with a nice growth of nearly 13 percent, increased earnings and further internationalization of our brand.

Sales amounted to 170 MSEK. Sales increased in all geographical regions fueled by innovations and effective marketing. Our gross margin reached 67.3 percent which is satisfactory. Costs have been kept well under control. Basically all increase in cost compared to last year is related to increase in marketing campaigns to back existing and new products world wide. The increase in cost first half 2017 amounted to 13 percent.

In our internationalization process, we have some countries where we are well-established in the local market and some countries where we work hard to gain market share to reach a more critical mass and a solid platform for future profits. Therefore, our EBITDA varies considerably from country to country. On a group level we reached a total EBITDA margin of 5.6 percent for the first half year which is below our long term ambitions but nonetheless increasing. With low debt and a low book value of our assets, financial costs and depre- ciation are comfortably low resulting in a profit after tax of 6.7 MSEK or 1.08 SEK per share for the first half year. Our balance is well trimmed and the inventory level is about right for our business.

Our three most important product categories: Vitality, Diet and Beauty are all developing well with a lot of international potential for further growth. During the first half year we have focused to prepare new innovative products for launch in the US market during the 2nd half of 2017. We also have some very exciting new products in preparation for test market in Scandinavia. Some of which will also introduce completely new technology to the industry.

The whole New Nordic team has made excellent efforts to reach the first half results and we are all excited about the second half of 2017. We are confident that we can take further market share in this growing food supplement market and increase our brand value and earnings.

Malmö 31st July, 2017

Karl Kristian Bergman Jensen, CEO

The information in this press release is that which New Nordic Healthbrands AB (publ) is required to disclose under Sweden's Securities Market Act. and made public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 9.00 (CET) on July 31st, 2017.

Contact:

Karl Kristian Bergman Jensen, CEO +46 40-239520 (switchboard),

Marinus Blåbjerg Sørensen, CFO +45 46323344 (switchboard)

New Nordic Healthbrands AB (publ), SE-211 43 Malmö, Sweden Phone +46-40-239520, fax: +46-40-239522, email: kk@newnordic.com. Registered office: Malmö, Reg. No. 556698-0453.

The following documents can be retrieved from beQuoted
New Nordic Pressrelease 2017-07-31 English.pdf
New Nordic Delarsrapport Q2 2017.pdf
New Nordic Interim Report Q2 2017.pdf

New Nordic Healthbrands AB (publ) was founded in 1990 and is quoted on NASDAQ OMX Stockholm since 2007. The company's busi- ness concept is to offer the most effective and safe food supplements and natural medicines for specific health conditions. New Nordic's branded products are now available in 33 countries in pharmacies and health stores. The New Nordic Group has it's own small sales and marketing companies in most European Countries, Canada and the US, to organize local marketing campaigns, serve the pharmacy and health retailers and serve the end consumers. In 2016, sales were 306 MSEK. All New Nordic products sold worldwide are manufactured in Scandinavia. For further information, visit www.newnordic.com.